[HTML][HTML] Progression in myeloid neoplasms: beyond the myeloblast

C Faria, A Tzankov - Pathobiology, 2024 - karger.com
Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-
myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN) …

Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with …

S Sadigh, DJ DeAngelo, JS Garcia, RP Hasserjian… - Modern Pathology, 2024 - Elsevier
In this study, we performed a comprehensive molecular analysis of paired skin and
peripheral blood/bone marrow (BM) samples from 17 patients with cutaneous myeloid or …

Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone

MR Luskin, AS Kim, SS Patel, K Wright… - Leukemia & …, 2020 - Taylor & Francis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic neoplasm of
presumed dendritic cell origin. BPDCN typically affects older men with cutaneous and often …

Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the …

K Hebeda, L Boudova, C Beham-Schmid, A Orazi… - Annals of …, 2021 - Springer
Disease progression in myelodysplastic syndromes (MDS) and myelodysplastic-
myeloproliferative neoplasms (MDS/MPN) is a major source of mortality. The European …

We Have More in Common Than What Sets Us Apart: Shared Founding Drivers in Myeloid Neoplasms and T-cell Lymphomas

MG Evans, AS Kim - The Hematologist, 2021 - ashpublications.org
A new year is an opportunity to reflect. More than six years ago in 2014, the phenomenon of
clonal hematopoiesis (CH) took the hematology community by storm. 1-3 Despite the catchy …